- Home
- TNGX vs TCMD Comparison
TNGX vs TCMD Comparison
Compare TNGX & TCMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNGX
- TCMD
- Stock Information
- Founded
- TNGX 2014
- TCMD 1995
- Country
- TNGX United States
- TCMD United States
- Employees
- TNGX N/A
- TCMD N/A
- Industry
- TNGX Biotechnology: Pharmaceutical Preparations
- TCMD Medical/Dental Instruments
- Sector
- TNGX Health Care
- TCMD Health Care
- Exchange
- TNGX Nasdaq
- TCMD Nasdaq
- Market Cap
- TNGX 413.6M
- TCMD 378.7M
- IPO Year
- TNGX N/A
- TCMD 2016
- Fundamental
- Price
- TNGX $3.92
- TCMD $17.85
- Analyst Decision
- TNGX Strong Buy
- TCMD Hold
- Analyst Count
- TNGX 8
- TCMD 1
- Target Price
- TNGX $13.14
- TCMD N/A
- AVG Volume (30 Days)
- TNGX 3.5M
- TCMD 310.3K
- Earning Date
- TNGX 11-06-2024
- TCMD 11-04-2024
- Dividend Yield
- TNGX N/A
- TCMD N/A
- EPS Growth
- TNGX N/A
- TCMD N/A
- EPS
- TNGX N/A
- TCMD 0.65
- Revenue
- TNGX $43,383,000.00
- TCMD $285,051,000.00
- Revenue This Year
- TNGX $25.55
- TCMD $8.83
- Revenue Next Year
- TNGX N/A
- TCMD $9.86
- P/E Ratio
- TNGX N/A
- TCMD $27.63
- Revenue Growth
- TNGX 15.67
- TCMD 5.31
- 52 Week Low
- TNGX $2.70
- TCMD $11.12
- 52 Week High
- TNGX $13.01
- TCMD $17.90
- Technical
- Relative Strength Index (RSI)
- TNGX 39.26
- TCMD 71.41
- Support Level
- TNGX $3.54
- TCMD $15.22
- Resistance Level
- TNGX $4.22
- TCMD $16.20
- Average True Range (ATR)
- TNGX 0.53
- TCMD 0.84
- MACD
- TNGX 0.13
- TCMD 0.16
- Stochastic Oscillator
- TNGX 48.61
- TCMD 99.01
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. Its program TNG908, is an MTA-cooperative inhibitor of PRMT5 designed to work selectively in cancer cells with an MTAP deletion. Its pipeline further consists of discovery programs such as, TNG462, TNG348, TNG260 and others for multiple cancer types with limited treatment options.
About TCMD Tactile Systems Technology Inc.
Tactile Systems Technology Inc is a medical technology company. The company is engaged in developing and providing medical devices for the treatment of chronic diseases. The firm's proprietary platform flexitouch system provides a home-based solution for lymphedema patients. The entire system is another home solution for patients with chronic swelling and actitouch system for chronic venous insufficiency patients that may be worn throughout the day.